Barham Abu Dayyeh
Mayo Clinic
Dr. Barham Abu Dayyeh serves as the Executive Director and Associate Dean for Innovation at Cedars-Sinai Medical Center in Los Angeles. In this role, he leads strategic initiatives in interventional gastroenterology, with a focus on the integration of advanced technologies to elevate the standard of patient care. As Director of Interventional Gastroenterology and Director of System Integration in Advanced Endoscopy, he oversees the development of high-value service lines and the implementation of novel therapeutic platforms, including robotics and regenerative therapies for the minimally invasive management of complex gastrointestinal diseases.
A recognized innovator in the field, Dr. Abu Dayyeh has pioneered multiple endoscopic procedures and medical technologies. His contributions span numerous patents, national an international innovation awards, and leadership of pivotal clinical trials that have shaped the endoscopic treatment landscape for obesity, metabolic disorders, and advanced gastrointestinal endoscopy.
Prior to joining Cedars-Sinai, Dr. Abu Dayyeh was Professor of Medicine at the Mayo Clinic, where he directed the Advanced Endoscopy Program and played a key role in institutional business development and innovation strategy. He has authored more than 380 peer-reviewed publications and is the recipient of multiple honors, including the Jordanian Star of Science Award and the Surgical Innovator Award from the American Society for Metabolic and Bariatric Surgery.
Dr. Abu Dayyeh remains deeply committed to advancing the field of interventional gastroenterology through clinical innovation, translational research, multidisciplinary collaboration, and mentorship.
Appearances
DateMay 8, 2023BACKGROUND: Sound evidence support the effectiveness of the transoral outlet reduction (TORe) with full-thickness endoscopic suturing (FTS) or argon plasma coagulation (APC) alone to address post-RYGB weight regain…Presenter
Speakers
Mayo ClinicUniversity of Sao Paulo Medical School- DateMay 9, 2023SOCIETY: ASGE
Presenter
Mayo Clinic - DateMay 6, 2023
Presenters
- DateMay 9, 2023Gastric fistula formation is a known complication of bariatric surgery. Many gastric fistulae can be managed endoscopically, however, it can be difficult to successfully treat chronic fistulae…
Presenter
Mayo ClinicSpeakers
- DateMay 9, 2023BACKGROUND: The field of bariatric endoscopy continues to evolve with the introduction of new technology and refinement of endoscopic techniques. Recently, the gastric antrum has gained interest as a potential novel therapeutic target…
Presenter
Speakers
- DateMay 9, 2023BACKGROUND: The field of bariatric endoscopy continues to evolve with the introduction of new technology and refinement of endoscopic techniques. Recently, the gastric antrum has gained interest as a potential novel therapeutic target…
Presenter
Speakers
- DateMay 6, 2023BACKGROUND: There is a lack of data on training benchmarks to define competence in colorectal EMR (C-EMR) among advanced endoscopy trainees (AETs). Previous pilot data from our group demonstrated a relatively low proportion of AETs achieve competence on key cognitive and technical aspects of C-EMR…
Presenter
Weill Cornell Medical CenterSpeakers
University of ChicagoMayo ClinicBrigham and Women's HospitalMayo Clinic - DateMay 6, 2023BACKGROUND: There is a lack of data on training benchmarks to define competence in colorectal EMR (C-EMR) among advanced endoscopy trainees (AETs). Previous pilot data from our group demonstrated a relatively low proportion of AETs achieve competence on key cognitive and technical aspects of C-EMR…
- DateMay 6, 2023BACKGROUND: There is a lack of data on training benchmarks to define competence in colorectal EMR (C-EMR) among advanced endoscopy trainees (AETs). Previous pilot data from our group demonstrated a relatively low proportion of AETs achieve competence on key cognitive and technical aspects of C-EMR…
Presenter
Mayo Clinic - DateMay 9, 2023BACKGROUND: To address the persistent ethnoracial and socioeconomic disparities in access to quality surgical cancer care, it is imperative to rigorously understand the role of clinician-level factors including clinician-to-clinician connectedness…
Presenter
Speakers
- DateMay 9, 2023BACKGROUND: Endoscopic Snare Papillectomy (ESP) is a minimally invasive option for the management of noninvasive ampullary adenomas…
Presenter
Speakers
University of PennsylvaniaMayo ClinicMayo ClinicMayo ClinicMayo ClinicMayo ClinicMayo Clinic - DateMay 8, 2023BACKGROUND & AIMS: Minimal prospective data are available on intraoperative pancreatoscopy (IOP) for the diagnostic work-up of intraductal papillary mucinous neoplasia (IPMN)…
Presenter
Speakers
Mayo ClinicMayo ClinicMayo Clinic MinnesotaMayo ClinicMayo Foundation for Medical Education and ResearchMayo College of MedicineMayo ClinicMayo Clinic MinnesotaMayo ClinicMayo Clinic - DateMay 7, 2023Please note that this session requires an additional registration fee to attend…
Presenters
University of Colorado School of MedicineBrigham and Women's HospitalMayo Clinic - DateMay 7, 2023Please note that this session requires an additional registration fee to attend…
Presenter
Mayo Clinic - DateMay 9, 2023Introduction: Transnasal endoscopy (TNE) is a valuable tool for endoscopic evaluation of the upper gastrointestinal tract while entirely avoiding the risk of general anesthesia in children…
Presenter
Speakers
Mayo ClinicMayo ClinicMayo Clinic MinnesotaMayo Foundation for Medical Education and ResearchMayo College of MedicineMayo Clinic - DateMay 8, 2023Background: Several studies have demonstrated targeted next-generation sequencing (NGS) of biliary brushings and/or biopsy specimens can improve the identification of neoplastic bile duct strictures…
Presenter
Speakers
Mayo Foundation for Medical Education and ResearchMayo ClinicMayo ClinicMayo ClinicMayo ClinicMayo Foundation for Medical Education and ResearchMayo ClinicMayo Clinic Minnesota - DateMay 6, 2023Background: Gastric sleeve stenosis (GSS) is an increasingly common adverse event following sleeve gastrectomy (SG) and thought to result from progressive rotation and/or scarring of the sleeve. Objective diagnostic criteria for this condition are lacking…
- DateMay 6, 2023Background: Gastric sleeve stenosis (GSS) is an increasingly common adverse event following sleeve gastrectomy (SG) and thought to result from progressive rotation and/or scarring of the sleeve. Objective diagnostic criteria for this condition are lacking…
Presenter
Weill Cornell Medical CenterSpeakers
University of ChicagoMayo ClinicBrigham and Women's HospitalMayo Clinic - DateMay 6, 2023Background: Gastric sleeve stenosis (GSS) is an increasingly common adverse event following sleeve gastrectomy (SG) and thought to result from progressive rotation and/or scarring of the sleeve. Objective diagnostic criteria for this condition are lacking…
Presenter
Mayo Clinic - DateMay 9, 2023Colorectal cancer (CRC) remains a leading cause of cancer related mortality worldwide…
Presenter
Speakers
Mayo ClinicMayo ClinicMayo Foundation for Medical Education and ResearchMayo Clinic FloridaMayo ClinicMayo ClinicMayo College of MedicineMayo ClinicMayo Clinic MinnesotaMayo ClinicMayo ClinicMayo Clinic Minnesota - DateMay 7, 2023EUS-guided gastroenterostomy (EUS-GE) is a novel method for palliating gastric outlet obstructon due to unresectable malignancies…
Presenter
Speakers
Mayo ClinicMayo Clinic MinnesotaMayo ClinicMayo Clinic - DateMay 18, 2024
Presenter
Mayo Clinic - DateMay 21, 2024Pancreatic cancer (PC) screening is recommended in high-risk individuals (HRIs) with familial and genetic risk factors. Endoscopic ultrasound (EUS) and magnetic resonance imaging (MRI) are used in combination as preferred screening modalities…
Presenter
Speakers
Mayo ClinicMayo Clinic MinnesotaMayo ClinicMayo Foundation for Medical Education and ResearchMayo College of MedicineMayo ClinicMayo Clinic MinnesotaMayo ClinicMayo Clinic Minnesota - DateMay 18, 2024Type II diabetes (T2D) pathogenesis is linked with diabetes-associated duodenal alterations, presenting a potential regnerative therapeutic target…
Presenter
Mayo ClinicSpeakers
Mayo Clinic MinnesotaMayo Clinic - DateMay 18, 2024BACKGROUND: Obesity is considered a major risk factor for developing multiple complications and medical conditions including type-2 diabetes mellitus (T2DM). Multiple scores (i.e., Individualized Metabolic Surgery [IMS], DiaRem, advanced DiaRem, and Robert et Al…
Presenter
Speakers
Mayo ClinicMayo ClinicMayo Foundation for Medical Education and Research - DateMay 19, 2024BACKGROUND AND AIMS: The Primary Obesity Surgery Endoluminal 2.0 (POSE2.0) is an endoscopic gastric remodeling procedure that utilizes an incisionless operating platform (IOP, San Clemente, CA) to remodel the stomach and alter appetite (FIGURE 1)…
Presenter
Mayo ClinicSpeakers
Mayo ClinicMayo Clinic MinnesotaBrigham and Women's Hospital - DateMay 19, 2024In the evolving treatment landscape for T2D, the duodenum, a key site for nutrient sensing and glucose metabolism regulation, presents a compelling target for new therapeutic approaches that seek to improve insulin sensitivity and glucose homeostasis…
- DateMay 19, 2024BACKGROUND: The duodenum is integral as a metabolic signaling center, making it a promising therapeutic target for Type 2 Diabetes (T2D). However, the specific pathophysiological alterations in the duodenum under metabolic stress, especially in human, are not well-understood…
- DateMay 19, 2024INTRODUCTION: Clinicians struggle with classifying biliary tract strictures as being benign or malignant due to inadequate sampling techniques. Current sampling modalities include brush cytology (BC) and forceps biopsy (FB), which have poor sensitivity for identifying malignancy…
Presenter
Speakers
University of Massachusetts Chan Medical SchoolMayo ClinicMayo ClinicMayo ClinicMayo ClinicMayo Clinic MinnesotaUniversity of Virginia School of MedicineMayo Clinic - DateMay 19, 2024Introduction: The X-Tack system is a device used for soft-tissue approximation in minimally invasive endoscopic procedures, and for stent or enteral tube fixation. Since it is a relatively new device, sparse data exists on potential adverse events that may occur following its use…
Presenter
Speakers
Mayo clinicMayo ClinicMayo ClinicMayo Clinic - DateMay 20, 2024BACKGROUND: Roux-en-Y Gastric Bypass (RYGB) is often preferred for patients with obesity and gastroesophageal reflux disease (GERD), as it typically reduces reflux symptoms. However, post-RYGB, GERD symptoms and the use of proton pump inhibitors (PPIs) remain prevalent…
Presenter
Speakers
- DateMay 20, 2024Obesity and type-2 diabetes mellitus (T2DM) are two inter-related chronic diseases with significant medical and financial burden. T2DM results in detrimental vascular complications including microvascular and macrovascular diseases…
Presenter
Speakers
Mayo ClinicMayo ClinicMayo Foundation for Medical Education and Research 
DateMay 19, 2024SOCIETY: ASGEModerators
Mercy Fitzgerald HospitalMayo Clinic- DateMay 3, 2025
Speakers
Mayo ClinicUC San Diego Health
